BioSig Technologies, Valuation
| BSGM Stock | USD 0.49 0.06 10.91% |
BioSig Technologies, is overvalued. BioSig Technologies, shows a prevailing Real Value of $0.53 per share. The current price of the firm is $0.49. Our model approximates the value of BioSig Technologies, from analyzing the firm fundamentals such as Return On Equity of -59.77, shares outstanding of 14.12 M, and Operating Margin of (227.43) % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that BioSig Technologies,'s price fluctuation is out of control at this time. Calculation of the real value of BioSig Technologies, is based on 3 months time horizon. Increasing BioSig Technologies,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioSig otc stock is determined by what a typical buyer is willing to pay for full or partial control of BioSig Technologies, Common. Since BioSig Technologies, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioSig OTC Stock. However, BioSig Technologies,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.49 | Real 0.53 | Hype 0.45 | Naive 0.55 |
The intrinsic value of BioSig Technologies,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioSig Technologies,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioSig Technologies, Common helps investors to forecast how BioSig otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioSig Technologies, more accurately as focusing exclusively on BioSig Technologies,'s fundamentals will not take into account other important factors: BioSig Technologies, Total Value Analysis
BioSig Technologies, Common is currently forecasted to have valuation of 6.43 M with market capitalization of 6.64 M, debt of 452 K, and cash on hands of 887 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioSig Technologies, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.43 M | 6.64 M | 452 K | 887 K |
BioSig Technologies, Investor Information
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.86. BioSig Technologies, last dividend was issued on the 11th of September 2018. The entity had 1:10 split on the 2nd of February 2024. Based on the key measurements obtained from BioSig Technologies,'s financial statements, BioSig Technologies, Common is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.BioSig Technologies, Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioSig Technologies, has an asset utilization ratio of 1.0 percent. This suggests that the OTC Stock is making $0.01 for each dollar of assets. An increasing asset utilization means that BioSig Technologies, Common is more efficient with each dollar of assets it utilizes for everyday operations.BioSig Technologies, Ownership Allocation
BioSig Technologies, Common shows 17.59 percent of its outstanding shares held by insiders and 3.04 percent owned by other corporate entities.BioSig Technologies, Profitability Analysis
The company reported the previous year's revenue of 18 K. Net Loss for the year was (28.69 M) with profit before overhead, payroll, taxes, and interest of 242 K.About BioSig Technologies, Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of BioSig Technologies, Common. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of BioSig Technologies, based exclusively on its fundamental and basic technical indicators. By analyzing BioSig Technologies,'s financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of BioSig Technologies,'s intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioSig Technologies,. We calculate exposure to BioSig Technologies,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioSig Technologies,'s related companies.BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.
8 Steps to conduct BioSig Technologies,'s Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates BioSig Technologies,'s potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioSig Technologies,'s valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioSig Technologies,'s financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioSig Technologies,'s revenue streams: Identify BioSig Technologies,'s primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioSig Technologies,'s industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioSig Technologies,'s growth potential: Evaluate BioSig Technologies,'s management, business model, and growth potential.
- Determine BioSig Technologies,'s financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioSig Technologies,'s estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BioSig Technologies, Growth Indicators
Investing in growth stocks can be very risky. If the company such as BioSig Technologies, does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 7.4 M |
Other Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.